Genetic Variants in Nicotinamide Adenine Dinucleotide (NAD) Synthesis Pathway
Identifying Genetic Variants in Nicotinamide Adenine Dinucleotide (NAD) Synthesis Pathway in Patients With Congenital Malformations
Sponsor: Mayo Clinic
A observational or N/A phase clinical study on Congenital Malformation and Vacterl Association, this trial is completed. The trial is conducted by Mayo Clinic and has accumulated 13 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
May 2024 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Feb 2023 — May 2024 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Nov 2022 — Feb 2023 [monthly]
Recruiting
▶ Show 8 earlier versions
-
Dec 2021 — Nov 2022 [monthly]
Recruiting
-
Nov 2021 — Dec 2021 [monthly]
Recruiting
-
Jan 2021 — Nov 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Sep 2020 — Nov 2020 [monthly]
Recruiting
-
Sep 2019 — Sep 2020 [monthly]
Recruiting
-
May 2019 — Sep 2019 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Feb 2019 — May 2019 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Mayo Clinic
For direct contact, visit the study record on ClinicalTrials.gov .